Kaoruko Shimizu Selected Research

Clinical Deterioration

1/2020

[A CASE OF SEVERE ASTHMA SWITCHED TO MEPOLIZUMAB DUE TO LATE-OCCURRING UNRESPONSIVENESS TO BENRALIZUMAB].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kaoruko Shimizu Research Topics

Disease

24	Asthma (Bronchial Asthma) 02/2024 - 06/2008
15	Chronic Obstructive Pulmonary Disease (COPD) 07/2023 - 10/2011
6	Inflammation (Inflammations) 01/2023 - 10/2011
3	Eosinophilia 07/2023 - 12/2010
2	Allergic Rhinitis 01/2021 - 07/2018
2	Emphysema 01/2019 - 01/2012
2	Tuberous Sclerosis (Bourneville's Disease) 01/2019 - 01/2018
2	Hyperplasia 01/2019 - 01/2018
2	Obstructive Lung Diseases (Obstructive Lung Disease) 01/2018 - 07/2014
2	Dyspnea (Shortness of Breath) 12/2014 - 10/2011
1	Respiratory Hypersensitivity 06/2022
1	Overweight 06/2022
1	Airway Remodeling 01/2022
1	Disease Progression 01/2022
1	Confusion (Bewilderment) 05/2021
1	Rhinosinusitis 01/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Clinical Deterioration 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Respiratory Sounds (Crackle) 10/2018
1	Eczema 10/2018
1	Obesity 07/2018
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2018
1	Pleural Effusion (Pleural Effusions) 12/2014
1	Bronchiolitis 12/2010
1	Sarcoidosis (Schaumann Disease) 10/2010
1	Pulmonary Sarcoidosis 09/2010
1	Rhinitis 05/2010

Drug/Important Bio-Agent (IBA)

5	Bronchodilator Agents (Bronchodilators)IBA 07/2023 - 10/2011
4	Biomarkers (Surrogate Marker)IBA 07/2023 - 12/2014
4	Carbon MonoxideIBA 01/2023 - 01/2012
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2024 - 01/2020
3	GoldIBA 01/2023 - 01/2020
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2022
3	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 05/2014
3	Immunoglobulin E (IgE)IBA 12/2016 - 05/2010
2	trans-sodium crocetinate (crocetin)IBA 01/2019 - 01/2018
2	AdipokinesIBA 07/2018 - 12/2014
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2017 - 10/2016
2	AntigensIBA 12/2016 - 05/2010
2	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 01/2016 - 05/2014
2	montelukast (Singulair)FDA Link 01/2016 - 05/2014
2	Salmeterol Xinafoate (Serevent)FDA Link 01/2016 - 05/2014
2	Phenobarbital (Luminal)FDA Link 06/2015 - 01/2014
2	AntioxidantsIBA 07/2014 - 10/2011
2	arginylarginine (Arg-Arg)IBA 05/2014 - 06/2008
2	Prednisolone (Predate)FDA LinkGeneric 12/2010 - 09/2010
2	Mannose ReceptorIBA 10/2010 - 12/2009
1	Indicators and Reagents (Reagents)IBA 11/2023
1	Omalizumab (Xolair)FDA Link 01/2022
1	Interleukin-5 (Interleukin 5)IBA 01/2022
1	ChitinasesIBA 01/2022
1	CalciumIBA 08/2021
1	mepolizumabIBA 01/2020
1	benralizumabIBA 01/2020
1	Neutralizing AntibodiesIBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 12/2019
1	130-nm albumin-bound paclitaxelIBA 12/2019
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2019
1	CotinineIBA 10/2018
1	PeriostinIBA 07/2018
1	lipoarabinomannan (LAM)IBA 01/2018
1	Cholinergic Agents (Cholinergics)IBA 01/2017
1	indacaterolIBA 10/2016
1	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 10/2016
1	Thyroglobulin FDA Link 12/2014
1	AdiponectinIBA 12/2014
1	LeptinIBA 12/2014
1	CatalaseIBA 07/2014
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2013
1	UteroglobinIBA 11/2013
1	Expectorants (Mucolytics)IBA 10/2011
1	C-Type Lectins (C-Type Lectin)IBA 10/2010
1	SteroidsIBA 06/2008

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2019 - 10/2011
1	Bronchial Thermoplasty 01/2024
1	Precision Medicine 10/2011
1	Aftercare (After-Treatment) 12/2010